Nefopam

This MedLibrary.org supplementary page on Nefopam is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Nefopam
Systematic (IUPAC) name
5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine
Identifiers
CAS number 13669-70-0
ATC code N02BG06
PubChem 4450
Chemical data
Formula C17H19NO 
Mol. mass 253.34 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

POM(UK)

Routes Oral, Intravenous

Nefopam (marketed under the brandname Acupan) is an analgesic drug, developed in the early 1970s. It is widely used, mainly in European countries, for the relief of moderate to severe pain as an alternative to opioid analgesic drugs. Various studies have confirmed that nefopam has a potentiating (analgesic-sparing) effect on morphine and other opioids by broadening the antinociceptive action of the opioid and possibly other mechanisms, generally lowering the dose requirements of both when they are used concomitantly. (Pharmacol Biochem Behav. 2004 Apr;77(4):695-703)

Nefopam is also used to combat severe hiccups.

Contents

Use

Nefopam has additional action in the prevention of shivering, which may be a side effect of other drugs used in surgery.[1]

Nefopam at a dose of 30–120 mg is significantly more effective than aspirin as an analgesic,[2] although with a greater incidence of side effects such as sweating, dizziness and nausea, especially at higher doses.[3][4]

Nefopam is around half the potency and slightly less effective as an analgesic compared to morphine,[5][6] or oxycodone,[7] but tends to produce less side effects, does not produce respiratory depression,[8] and has much less abuse potential, and so is useful either as an alternative to opioids, or as an adjunctive treatment for use alongside opioid(s) or other analgesics.[9][10]

Pharmacology

The mechanism of action of nefopam is not well understood, although inhibition of serotonin, dopamine and noradrenaline reuptake is thought to be involved in its analgesic effects,[11][12][13] and there may be other modes of action such as through histamine H3 receptors[14] and glutamate.[15]

Abuse & Overdose

Abuse of nefopam and death from overdose have both been reported,[16][17] although these problems are less common with nefopam than with the opioid analgesic drugs.[18][19]

References

  1. ^ Alfonsi P, Adam F, Passard A, Guignard B, Sessler DI, Chauvin M (January 2004). "Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects.". Anesthesiology 100 (1): 37–43. doi:10.1097/00000542-200401000-00010. PMID 14695722. Retrieved on 2008-02-22. 
  2. ^ Cohen A, Hernandez CM (1976). "Nefopam hydrochloride: new analgesic agent.". Journal of International Medical Research 4 (2): 138–43. PMID 799984. Retrieved on 2008-02-22. 
  3. ^ Wang RI, Waite EM (July 1979). "The clinical analgesic efficacy of oral nefopam hydrochloride.". Journal of Clinical Pharmacology 19 (7): 395–402. PMID 479385. Retrieved on 2008-02-22. 
  4. ^ Pillans PI, Woods DJ (September 1995). "Adverse reactions associated with nefopam.". New Zealand Medical Journal 108 (1008): 382–4. PMID 7566787. Retrieved on 2008-02-22. 
  5. ^ Sunshine A, Laska E (November 1975). "Nefopam and morphine in man.". Clinical Pharmacology and Therapeutics 18 ((5 Pt 1)): 530–4. PMID 1102231. Retrieved on 2008-02-22. 
  6. ^ Phillips G, Vickers MD (October 1979). "Nefopam in postoperative pain.". British Journal of Anaesthesia 51 (10): 961–5. PMID 391253. Retrieved on 2008-02-22. 
  7. ^ Tigerstedt I, Tammisto T, Leander P (December 1979). "Comparison of the analgesic dose-effect relationships of nefopam and oxycodone in postoperative pain.". Acta Anaesthesiologica Scandinavica 23 (6): 555–60. PMID 397711. Retrieved on 2008-02-22. 
  8. ^ Gasser JC, Bellville JW (August 1975). "Respiratory effects of nefopam.". Clinical Pharmacology and Therapeutics 18 (2): 175–9. PMID 1097153. Retrieved on 2008-02-22. 
  9. ^ Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS (1980). "Nefopam: a review of its pharmacological properties and therapeutic efficacy.". Drugs 19 (4): 249–67. PMID 6991238. Retrieved on 2008-02-22. 
  10. ^ Kapfer B, Alfonsi P, Guignard B, Sessler DI, Chauvin M (January 2005). "Nefopam and ketamine comparably enhance postoperative analgesia.". Anesthesia and Analgesia 100 (1): 169–74. doi:10.1213/01.ANE.0000138037.19757.ED. PMID 15616073. Retrieved on 2008-02-22. 
  11. ^ Esposito E, Romandini S, Merlo-Pich E, Mennini T, Samanin R (September 9, 1986). "Evidence of the involvement of dopamine in the analgesic effect of nefopam.". European Journal of Pharmacology 128 (3): 157–64. doi:10.1016/0014-2999(86)90762-4. PMID 3098570. Retrieved on 2008-02-22. 
  12. ^ Marazziti D, Rotondo A, Ambrogi F, Cassano GB (1991). "Analgesia by nefopam: does it act through serotonin?". Drugs under Experimental and Clinical Research 17 (5): 259–61. PMID 1756689. Retrieved on 2008-02-22. 
  13. ^ Fuller RW, Snoddy HD (October 1993). "Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice.". Neuropharmacology 32 (10): 995–9. doi:10.1016/0028-3908(93)90064-A. 
  14. ^ Girard P, Pansart Y, Coppé MC, Verniers D, Gillardin JM (October 25, 2004). "Role of the histamine system in nefopam-induced antinociception in mice.". European Journal of Pharmacology 503 (1-3): 63–9. doi:10.1016/j.ejphar.2004.09.030. PMID 15496297. Retrieved on 2008-02-22. 
  15. ^ Verleye M, André N, Heulard I, Gillardin JM (July 9, 2004). "Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents.". Brain Research 1013 (2): 249–55. doi:10.1016/j.brainres.2004.04.035. PMID 15193535. Retrieved on 2008-02-22. 
  16. ^ Bismuth C, Fournier PE, Bavoux E, Husson O, Lafon D. Chronic abuse of the analgesic nefopam (Acupan). (French). Journal de Toxicologie Clinique et Experimentale. 1987 Sep-Oct;7(5):343-6.
  17. ^ Piercy DM, Cumming JA, Dawling S, Henry JA. Death due to overdose of nefopam. British Medical Journal (Clinical Research Edition). 1981 Dec 5;283(6305):1508-9.
  18. ^ Urwin SC, Smith HS. Fatal nefopam overdose. British Journal of Anaesthesia. 1999 Sep;83(3):501-2.
  19. ^ Villier C, Mallaret MP. Nefopam abuse. Annals of Pharmacotherapy. 2002 Oct;36(10):1564-6.

Wikipedia content modification information:

  • This page was last modified on 11 June 2008, at 23:54.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Nefopam".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.